Abstract: A pharmaceutical composition comprising at least one antifungal agent and at least one chelator, and a method for administering the pharmaceutical composition to a patient having a fungal infection. Another aspect provides a pharmaceutical composition comprising at least one chelator, at least one antifungal agent and at least one monoclonal antibody, wherein the monoclonal antibody is operatively attached to the chelator, and a method of administering this composition to a patient having a fungal infection.
Type:
Grant
Filed:
August 25, 1998
Date of Patent:
December 26, 2000
Assignees:
Wake Forest University, Board of Regents, The University of Texas Sysytem